IL300133A - Anti-integrin antibody compositions in cell 7 and devices - Google Patents
Anti-integrin antibody compositions in cell 7 and devicesInfo
- Publication number
- IL300133A IL300133A IL300133A IL30013323A IL300133A IL 300133 A IL300133 A IL 300133A IL 300133 A IL300133 A IL 300133A IL 30013323 A IL30013323 A IL 30013323A IL 300133 A IL300133 A IL 300133A
- Authority
- IL
- Israel
- Prior art keywords
- devices
- antibody formulations
- integrin beta7
- beta7 antibody
- integrin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063059427P | 2020-07-31 | 2020-07-31 | |
| PCT/US2021/043690 WO2022026699A1 (fr) | 2020-07-31 | 2021-07-29 | Formulations d'anticorps anti-intégrine bêta7 et dispositifs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL300133A true IL300133A (en) | 2023-03-01 |
Family
ID=77693570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL300133A IL300133A (en) | 2020-07-31 | 2021-07-29 | Anti-integrin antibody compositions in cell 7 and devices |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP4188958A1 (fr) |
| JP (1) | JP2023536158A (fr) |
| KR (1) | KR20230041071A (fr) |
| AR (1) | AR123085A1 (fr) |
| AU (1) | AU2021316017A1 (fr) |
| BR (1) | BR112023001734A2 (fr) |
| CA (1) | CA3190109A1 (fr) |
| IL (1) | IL300133A (fr) |
| MX (1) | MX2023001157A (fr) |
| TW (1) | TW202222832A (fr) |
| WO (1) | WO2022026699A1 (fr) |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| US5959177A (en) | 1989-10-27 | 1999-09-28 | The Scripps Research Institute | Transgenic plants expressing assembled secretory antibodies |
| WO1991010741A1 (fr) | 1990-01-12 | 1991-07-25 | Cell Genesys, Inc. | Generation d'anticorps xenogeniques |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| CA2089661C (fr) | 1990-08-29 | 2007-04-03 | Nils Lonberg | Animaux transgeniques non humains capables de produire des anticorps heterologues |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| JP3951062B2 (ja) | 1991-09-19 | 2007-08-01 | ジェネンテック・インコーポレーテッド | 少なくとも遊離のチオールとして存在するシステインを有する抗体フラグメントの大腸菌での発現、２官能性Ｆ（ａｂ’）２抗体の産生のための使用 |
| US5789199A (en) | 1994-11-03 | 1998-08-04 | Genentech, Inc. | Process for bacterial production of polypeptides |
| US5840523A (en) | 1995-03-01 | 1998-11-24 | Genetech, Inc. | Methods and compositions for secretion of heterologous polypeptides |
| CA2761116A1 (fr) | 1995-04-27 | 1996-10-31 | Amgen Fremont Inc. | Anticorps humains derives d'une xenosouris immunisee |
| AU2466895A (en) | 1995-04-28 | 1996-11-18 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| PT1500329E (pt) | 1996-12-03 | 2012-06-18 | Amgen Fremont Inc | Anticorpos humanos que se ligam especificamente ao tnf alfa humano |
| US6040498A (en) | 1998-08-11 | 2000-03-21 | North Caroline State University | Genetically engineered duckweed |
| ES2248127T3 (es) | 1999-10-04 | 2006-03-16 | Medicago Inc. | Metodo para regular la transcripcion de genes foraneos en presencia de nigtrogeno. |
| US7125978B1 (en) | 1999-10-04 | 2006-10-24 | Medicago Inc. | Promoter for regulating expression of foreign genes |
| JP4340062B2 (ja) | 2000-10-12 | 2009-10-07 | ジェネンテック・インコーポレーテッド | 粘度の減少した濃縮タンパク質製剤 |
| US20050158303A1 (en) | 2003-04-04 | 2005-07-21 | Genentech, Inc. | Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations |
| CN101094868B (zh) | 2004-09-03 | 2013-07-10 | 健泰科生物技术公司 | 人源化的抗-β7拮抗剂及其应用 |
| WO2009140684A2 (fr) | 2008-05-16 | 2009-11-19 | Genentech, Inc. | Utilisation de biomarqueurs pour évaluer le traitement de troubles inflammatoires gastro-intestinaux avec des antagonistes de l'intégrine bêta7 |
| TW201039854A (en) | 2009-03-06 | 2010-11-16 | Genentech Inc | Antibody formulation |
| KR101884406B1 (ko) * | 2011-05-02 | 2018-08-02 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 항-α4β7 항체에 대한 제형 |
| WO2012173553A1 (fr) | 2011-06-17 | 2012-12-20 | Shl Group Ab | Dispositif d'injection |
| US9132236B2 (en) | 2011-06-17 | 2015-09-15 | Shl Group Ab | Injection device |
| EP3933401A3 (fr) | 2013-03-27 | 2022-04-13 | F. Hoffmann-La Roche AG | Utilisation de biomarqueurs pour évaluer le traitement de troubles inflammatoires gastro-intestinaux avec des antagonistes de l'intégrine beta7 |
| AR099856A1 (es) | 2014-03-27 | 2016-08-24 | Genentech Inc | Métodos para diagnosticar y tratar la enfermedad de intestino inflamado |
| CN107257693A (zh) * | 2015-02-26 | 2017-10-17 | 豪夫迈·罗氏有限公司 | 治疗Crohn病的整联蛋白β7拮抗剂和方法 |
| US20230033021A1 (en) * | 2018-06-20 | 2023-02-02 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an integrin inhibitor |
-
2021
- 2021-07-29 IL IL300133A patent/IL300133A/en unknown
- 2021-07-29 TW TW110127937A patent/TW202222832A/zh unknown
- 2021-07-29 CA CA3190109A patent/CA3190109A1/fr active Pending
- 2021-07-29 MX MX2023001157A patent/MX2023001157A/es unknown
- 2021-07-29 EP EP21766732.8A patent/EP4188958A1/fr not_active Withdrawn
- 2021-07-29 JP JP2023506189A patent/JP2023536158A/ja active Pending
- 2021-07-29 AU AU2021316017A patent/AU2021316017A1/en active Pending
- 2021-07-29 AR ARP210102115A patent/AR123085A1/es unknown
- 2021-07-29 BR BR112023001734A patent/BR112023001734A2/pt not_active Application Discontinuation
- 2021-07-29 KR KR1020237006223A patent/KR20230041071A/ko unknown
- 2021-07-29 WO PCT/US2021/043690 patent/WO2022026699A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| KR20230041071A (ko) | 2023-03-23 |
| EP4188958A1 (fr) | 2023-06-07 |
| TW202222832A (zh) | 2022-06-16 |
| CA3190109A1 (fr) | 2022-02-03 |
| AR123085A1 (es) | 2022-10-26 |
| AU2021316017A1 (en) | 2023-02-16 |
| BR112023001734A2 (pt) | 2023-02-28 |
| JP2023536158A (ja) | 2023-08-23 |
| MX2023001157A (es) | 2023-02-22 |
| WO2022026699A1 (fr) | 2022-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3930676T3 (en) | Polyribonucleotides and cosmetic uses thereof | |
| CA192596S (en) | Cosmetics bottle | |
| IL290141A (en) | Formulations of anti-pvrig antibodies and uses thereof | |
| CA196076S (en) | Cosmetic bottle | |
| IL309884A (en) | Immunoconjugates and methods | |
| GB201819321D0 (en) | Cavities and active regions | |
| GB2584733B (en) | Secure ultra wide band ranging | |
| GB2563725B (en) | Minimizing ringing in wide band gap semiconductor devices | |
| IL287003A (en) | Anti-integrin antibodies and their uses | |
| SG11202002414SA (en) | Hair care compositions and methods | |
| SG11202111188VA (en) | Anti-cd40 antibody and use thereof | |
| IL288944A (en) | Caffeine transmuted with deuterium and its uses | |
| SG10202003748WA (en) | Semiconductor devices and methods of operating the same | |
| IL299101A (en) | Formulations of non-porcine origin and methods for their preparation | |
| CA196074S (en) | Cosmetic bottle | |
| IL311070A (en) | Anti-PSMA antibodies and uses thereof | |
| EP3962404A4 (fr) | Procédés et dispositifs orthodontiques | |
| IL300133A (en) | Anti-integrin antibody compositions in cell 7 and devices | |
| EP3792257C0 (fr) | Composé de défactinib deutéré et son utilisation | |
| PL4198001T3 (pl) | Kompleks Pt-bifenyl-jod i kompleks Pt-bifenyl-brom | |
| IL289531A (en) | cd38 binding agents and uses thereof | |
| GB2600270B (en) | Polymer-comrprising medical devices and uses thereof | |
| IL288828A (en) | Binding factors - cd38 and their use | |
| IL287503A (en) | Thio-semicarbazide compounds and their use | |
| IL287477A (en) | Anti-cd38 antibodies and formulations |